Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors

被引:28
|
作者
Kannan, R
Ruff, M
Kochins, JG
Manly, SP
Stoll, I
El Fahime, M
Noël, A
Foidart, JM
Rio, MC
Dive, V
Basset, P
机构
[1] Univ Strasbourg 1, IGBMC, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
[3] Univ Liege, Lab Biol Tumeurs & Dev, B-4000 Liege, Belgium
[4] CEA, Dept Ingn & Etud Prot, F-91191 Gif Sur Yvette, France
关键词
alpha-1 proteinase inhibitor; cephalosporin; matrix metalloproteinase inhibitors; stromelysin-3;
D O I
10.1006/prep.1999.1068
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The matrix metalloproteinase (MMP) stromelysin-3 (ST3) has been shown to be involved in malignant tumor progression and therefore represents an attractive therapeutical target. In order to screen for ST3 synthetic inhibitors, we have produced and purified the catalytic domain of ST3, matrilysin, stromelysin-a, and membrane type-1 MMP from inclusion bodies in a bacterial system. Our strategy allowed the purification of MMPs directly in the active form, thereby avoiding in vitro activation. A total of 140,000 synthetic compounds from the Bristol-Myers Pharmaceutical Research Institute chemical deck were tested, using a substrate-based colorimetric enzymatic assay, in which ST3 activity was evaluated through its ability to cleave and inactivate alpha-1 proteinase inhibitor. One ST3 inhibitor belonging to the cephalosporin family of antibiotics was thereby identified. (C) 1999 Academic Press.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [31] Bicyclic heterocycles as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Li, Jie Jack
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [32] MATRIX METALLOPROTEINASE-3 (STROMELYSIN-1) - IDENTIFICATION AS THE CARTILAGE ACID METALLOPROTEASE AND EFFECT OF PH ON CATALYTIC PROPERTIES AND CALCIUM AFFINITY
    WILHELM, SM
    SHAO, ZH
    HOUSLEY, TJ
    SEPERACK, PK
    BAUMANN, AP
    GUNJASMITH, Z
    WOESSNER, JF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (29) : 21906 - 21913
  • [33] Production of Active MMP7 in E. coli and Its Application for Metalloproteinase Inhibitors Screening
    Katsuno, H.
    Shirakawa, R.
    Miyazaki, K.
    Ozeki, Y.
    Yasumitsu, H.
    PROTEIN AND PEPTIDE LETTERS, 2010, 17 (05): : 568 - 572
  • [34] Virtual Screening: Using Molecular Docking and 3D-QSAR Analysis of Matrix Metalloproteinase Inhibitors
    Amador-Falcon, Laura
    Rodriguez-Clavijo, Daniela
    Baldiris-Avila, Rosa
    Valdiris-Avila, Veronica
    Salgado-Moran, Guillermo
    Glossman-Mitnik, Daniel
    Vivas-Reyes, Ricardo
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2013, 60 (10) : 1212 - 1224
  • [35] Computational screening of matrix metalloproteinase 3 inhibitors to counteract skin aging from phytochemicals of Nelumbo nucifera Gaertn
    Bisht, Amisha
    Tewari, Disha
    Rawat, Kalpana
    Rawat, Shilpi
    Almoyad, Mohammad Ali Abdullah
    Wahab, Shadma
    Kumar, Sanjay
    Chandra, Subhash
    THEORETICAL CHEMISTRY ACCOUNTS, 2024, 143 (06)
  • [36] Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Li, Jie Jack
    Nahra, Joe
    Johnson, Adam R.
    Bunker, Amy
    O'Brien, Patrick
    Yue, Wen-Song
    Ofwine, Daniel F.
    Man, Chiu-Fai
    Baragi, Vijay
    Kilgore, Kenneth
    Dyer, Richard D.
    Han, Hyo-Kyung
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 835 - 841
  • [37] General and specific host responses to bacterial infection in Peyer's patches:: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection
    Handley, Scott A.
    Miller, Virginia L.
    MOLECULAR MICROBIOLOGY, 2007, 64 (01) : 94 - 110
  • [38] Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors
    Tawa, P
    Hell, K
    Giroux, A
    Grimm, E
    Han, Y
    Nicholson, DW
    Xanthoudakis, S
    CELL DEATH AND DIFFERENTIATION, 2004, 11 (04): : 439 - 447
  • [39] Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors
    P Tawa
    K Hell
    A Giroux
    E Grimm
    Y Han
    D W Nicholson
    S Xanthoudakis
    Cell Death & Differentiation, 2004, 11 : 439 - 447
  • [40] 3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors
    Singh, Udghosh
    Gangwal, Rahul P.
    Prajapati, Rameshwar
    Dhoke, Gaurao V.
    Sangamwar, Abhay T.
    MOLECULAR SIMULATION, 2013, 39 (05) : 385 - 396